Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Bayer presents novel dual sGC activators and PDE5 inhibitors

Sep. 4, 2015

Reduced dose of IL-37 attenuates arterial calcification

Sep. 3, 2015

Nissan Chemical Industries ends license agreement with Teijin Pharma and BMS for NTC-801

Sep. 3, 2015

GS-6615 shows short-term efficacy for the treatment of arrhythmia

Sep. 3, 2015

Juventas reports 1-year findings from phase II STOP-HF trial

Sep. 2, 2015

Bayer expands finerenone program with three phase III studies

Sep. 1, 2015

Celyad and Medisun sign license agreement for C-Cure in Greater China

Aug. 31, 2015

Work at Merck & Co. leads to identification of mineralcorticoid receptor antagonists

Aug. 31, 2015

Phase III data show advantage of ambrisentan-tadalafil combination in PAH

Aug. 28, 2015

Daiichi Sankyo discloses novel UR-2 receptor antagonists

Aug. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...